“…Therefore, we conducted antimicrobial susceptibility testing for all 276 isolates to select a representative isolate (an E. coli isolate that showed the broadest antimicrobial resistance profile) from each animal to calculate the prevalence of MDR E. coli among dogs and cats. The phenotypic antimicrobial susceptibility of these E. coli isolates was conducted using the microdilution method according to the Clinical & Laboratory Standards Institute (CLSI) guideline as previously described ( 52 , 53 ). In the assay, we tested bacterial susceptibility to eight antimicrobials, including amoxicillin/clavulanic acid (AMC, 0.5/0.25 to 64/32 mg/L), ceftriaxone (AXO, 0.015 to 8 mg/L), trimethoprim/sulfamethoxazole (SXT, 0.125/2.375 to 16/304 mg/L), nalidixic acid (NAL, 0.5 to 64 mg/L), ciprofloxacin (CIP, 0.015 to 8 mg/L), temocillin (TEM, 0.06 to 16 mg/L), colistin (CST, 0.06 to 8 mg/L), and imipenem (IMI, 0.015 to 8 mg/L) (Sangon, Shanghai, China).…”